GlobeNewswire

Juniper Networks Wins "Best of Show" Top Awards at Interop Tokyo 2018

Dela

Juniper's MX10008 Universal Chassis and Contrail Enterprise Multicloud Emerge as Grand Prix Winners at Prestigious Awards Ceremony

 

TOKYO, June 14, 2018 (GLOBE NEWSWIRE) -- Juniper Networks (NYSE:JNPR), an industry leader in automated, scalable and secure networks, today announced that it has captured multiple top honors at Interop Tokyo 2018 for the 12th straight year. The recognition reflects the company's consistent commitment toward delivering innovative and industry-leading networking technology while simplifying the complexities of networking.

Maintaining its award winning-streak at the influential trade show, Juniper triumphed in the following categories this year:

  • "Best of Show" Grand Prix Award (Network Infrastructure): Juniper Networks MX10008 Universal Chassis
  • "Best of Show" Grand Prix Award (Cloud Computing): Contrail Enterprise Multicloud by Juniper Networks
  • "Best of Show" Runners-Up Award (Security): Juniper Networks ATP Appliance
  • "Best of Show" Special Award (Security): Juniper Networks SRX4600 Services Gateway

Continuing Juniper's proud tradition of receiving consecutive "Best of Show" awards at Interop Tokyo since 2007, a prominent judging panel of industry experts and executives selected Juniper's products as award winners from among hundreds of nominations across the industry. Recent Juniper award-winners have included the QFX10008QFX5110 and the MX10003.

As one of the largest network computing trade shows in Asia, Interop Tokyo is renowned for being a top global business technology event, showcasing the very latest in cutting-edge networking products, solutions and services from vendors across the world. This year, Interop Tokyo 2018 attracted more than 140,000 attendees (including co-located events) and featured major keynote addresses and full-fledged conference programs, as well as an associated expo area for showcases by vendors.

Product Highlights:

Juniper Networks MX10008 Universal Chassis

  • The MX10008 completes Juniper's universal chassis portfolio that also includes the PTX and QFX chassis and continues service-scale innovation to usher in the next era of carrier, enterprise and cloud networking.
  • Customers now can have a singular chassis to accommodate a variety of line cards and software for different use-cases, enabling customers to do more with less while simplifying network design and reducing OPEX.
  • In addition, the MX10008 also brings industry-leading and space-saving scale for edge routers at 19.2 Tbps, while also improving per-slot economics for service scale at ~0.6 watts per gigabit.

Contrail Enterprise Multicloud by Juniper Networks

  • Contrail Enterprise Multicloud is the only multicloud-ready orchestration and analytics platform, for any cloud and any workload, across multivendor environments.
  • Integrating both overlay and underlay management into an open platform, Contrail Enterprise Multicloud streamlines workflows and improves end-to-end visibility.
  • Featuring end-to-end policy and control capability, Contrail Enterprise Multicloud enables users to have a single tool for orchestration across overlay and fabric management, bare metal servers, virtual machines, containers and networking devices, private and public clouds and security management.
  • Based on open interfaces and standard protocols, Contrail Enterprise Multicloud can be inserted into diverse networking environments to avoid unnecessary vendor lock-in, all while enabling a clear path toward a secure and automated multicloud.

Juniper Networks Advanced Threat Prevention (ATP) Appliance

  • The ATP Appliance provides comprehensive on-premise protection against a sophisticated ever-changing threat landscape.
  • Utilizing advanced machine learning and behavioral analysis, the ATP Appliance identifies existing and unknown advanced threats in near real-time.
  • With an open API architecture, the ATP Appliance integrates with third-party security devices for seamless, automatic threat mitigation.
  • The ATP Appliance is available in both physical (all-in-one or distributed mode deployment) and virtual (distributed mode only) form factors.

Juniper Networks SRX4600 Services Gateway

  • The high-performance SRX4600 next-generation firewall offers fast, scalable protection across the enterprise private cloud, campus networks, cloud service providers and telcos alike
  • With integrated malware prevention and a full suite of next-generation services, the SRX4600 is optimized to provide consistent and seamless protection across diverse environments
  • As the center point of defense, the SRX4600 offers unprecedented command over your entire security infrastructure, allowing for 'single pane of glass' management through Junos Space Security Director

Supporting Quote

"We are delighted to once again continue Juniper Networks' proud tradition of capturing multiple prestigious awards at Interop Tokyo, across the Network Infrastructure, Cloud Computing and Security categories. It's a major honor to be consecutively recognized every year since 2007 by the esteemed panel, and a strong testament to our commitment of continually challenging the complexities across networking - all while consistently engineering industry-leading products and solutions for our customers."

- Mike Marcellin, SVP and chief marketing officer, Juniper Networks

Additional Resources:

About Juniper Networks
Juniper Networks simplifies the complexities of networking with products, solutions and services in the cloud era to transform the way we connect, work and live. We remove the traditional constraints of networking to enable our customers and partners to deliver automated, scalable and secure networks that connect the world. Additional information can be found at Juniper Networks (www.juniper.net) or connect with Juniper on TwitterLinkedIn and Facebook.

Juniper Networks, the Juniper Networks logo, Juniper and Junos are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.

Media Relations:
Juniper Networks
Kenneth Chew
+65 6511 3529
kchew@juniper.net




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Juniper Networks via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development delays publication of its Annual Report for 2018 and changes date for the Annual General Meeting26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SWEDEN - 26 April 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that The Board of Directors has decided to delay the publication of its Annual Report for 2018. Karolinska Development has changed the date for the Annual General Meeting to June 26, 2019. The date for publication of the Annual Report for 2018 has been changed from April 26 to April 30, 2019. Karolinska Development has changed the date for the Annual General Meeting from June 4 to June 26, 2019. Notice to the Annual General Meeting will be published in a separate press release. For more information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, CFO, Karolinska Development AB Phone: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TO THE EDITORS About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investmen

Karolinska Development senarelägger publicering av årsredovisningen för 2018 och meddelar nytt datum för årsstämma26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 26 april 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen har beslutat att senarelägga publiceringen av årsredovisningen för 2018. Karolinska Development har ändrat datum för årsstämman till den 26 juni 2019. Publiceringen av årsredovisningen för 2018 flyttas från den 26 april till den 30 april 2019. Karolinska Development har ändrat datum för årsstämman från den 4 juni till den 26 juni 2019. Kallelse till årsstämman kommer att publiceras senare i ett separat pressmeddelande. För ytterligare information, vänligen kontakta: Viktor Drvota, vd, Karolinska Development AB Tel: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, finanschef, Karolinska Development AB Tel: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TILL REDAKTÖRERNA Om Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) är ett nordiskt investmentbolag inom life science. Bolaget fokuserar p

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPressmeddelande

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum